Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021.
Holly N BamberJon Jin KimBen C ReynoldsJavairiya AfzaalAndrew J LunnPatrick J TigheWilliam L IrvingAlexander W TarrPublished in: Pediatric nephrology (Berlin, Germany) (2023)
Anti-SARS-CoV-2 seroprevalence was low in 2020 and increased in early 2021. Serological surveillance complements nucleic acid detection and antigen testing to build a greater picture of the epidemiology of COVID-19 and is therefore important to guide public health responses. A higher resolution version of the Graphical abstract is available as Supplementary information.